Real-world study of Chinese medicine for chikungunya fever
Part of Infections clinical trials.
This study looks at how well Chinese medicine, Western medicine, or a mix of both works for people with chikungunya fever. It's a real-world study, meaning it follows what happens in everyday medical care, to see which approach helps patients feel better faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chikungunya fever or your doctor strongly suspects it.
- Your symptoms started within the past 3 days.
- You are willing to take either Chinese medicine, Western medicine, or a combination of both, as prescribed by your doctor.
- You do not have a severe case of chikungunya that requires hospital care for complications.
- You have not joined another drug study in the last 3 months.
- You are willing to sign a consent form agreeing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an herbal injection called Reduning to see if it safely reduces fever and relieves pain from chikungunya, a mosquito-borne virus. It may help you feel better faster if you're in the early stage of the illness.
This study tests an experimental vaccine designed to protect against chikungunya, a mosquito-borne virus that causes fever and joint pain. The trial will evaluate the vaccine's safety and immune response in healthy adults.
This trial tests a combination of two traditional Chinese herbal formulas (Yinqiaosan and Maxingganshitang) to see if they can help people with mild to moderate COVID-19 recover faster. It's for adults who have had symptoms for no more than 3 days and have been diagnosed with a specific Chinese medicine pattern.
This trial tests an experimental chikungunya vaccine (made from a virus-like particle) to see if it prevents the disease. It is for healthy teens and adults who have not had chikungunya before.
This study tests a new vaccine to protect against chikungunya virus, a disease spread by mosquitoes that causes fever and joint pain. The study measures how well your immune system responds to the vaccine and tracks any side effects.
This study looks at how well the VLA1553 vaccine prevents chikungunya disease in parts of Brazil where the vaccine is being offered as part of a pilot program. If you live in one of those areas and have had symptoms that might be chikungunya, this study will use your health records and blood tests to check how effective the vaccine is.
Hear when a new Chikungunya Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.